Mitsubishi Chemical Medience Clears FDA For Cardiac Biomarker Testing
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Chemical Medience Corporation obtained U.S. FDA 510(k) premarketing clearance for PATHFAST cTnI-II (cardiac troponin I) diagnostic test